Ian Moore

Nessuna posizione attualmente

Patrimonio netto: 77 744 $ in data 30/06/2026

Health Technology

Consumer Services

Health Services

Profilo

Ian Roger Moore served as the Chairman of Novo Nordisk Pharma Ltd. from 2005 to 2007.
He also worked as an Independent Non-Executive Director at Proteomics International Laboratories Ltd. from 2016 to 2024.
Additionally, he was a Member-Management Board at Novo Nordisk A. Mr. Moore completed his undergraduate degree at The University of Sydney.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valutazione	Data di valutazione
PROTEOMICS INTERNATIONAL LABORATORIES LTD. 0,59%	08/11/2024	975.824 ( 0,59% )	77 744 $	30/06/2026

Precedenti posizioni note di Ian Moore

Società	Posizione	Fine
PROTEOMICS INTERNATIONAL LABORATORIES LTD	Direttore/Membro del Consiglio	08/11/2024
Novo Nordisk Pharma Ltd. Novo Nordisk Pharma Ltd. Pharmaceuticals: MajorHealth Technology Produces drugs and insulins	Presidente	01/01/2007
NOVO NORDISK A/S	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Ian Moore

Formazione di Ian Moore

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Ian Moore

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
Novo Nordisk A/S Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care	Health Technology
The University of Sydney The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novo Nordisk Pharma Ltd. Novo Nordisk Pharma Ltd. Pharmaceuticals: MajorHealth Technology Produces drugs and insulins	Health Technology
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd. Medical/Nursing ServicesHealth Services Provides biological research and drug discovery services	Health Services